SM
SG3 Management Portfolio holdings
AUM
$6.45K
This Quarter Return
+0.56%
1 Year Return
-62.95%
3 Year Return
-60.35%
5 Year Return
-56.94%
10 Year Return
–
AUM
$282M
AUM Growth
+$282M
(+20%)
Cap. Flow
+$44.5M
Cap. Flow
% of AUM
15.78%
Top 10 Holdings %
Top 10 Hldgs %
41.57%
Holding
793
New
124
Increased
53
Reduced
53
Closed
143
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$40M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$10.3M |
| 3 |
Bausch Health
BHC
|
$7.27M |
| 4 |
Albemarle
ALB
|
$6.79M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$6.66M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$24.4M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$10M |
| 3 |
Amgen
AMGN
|
$7.8M |
| 4 |
Pinduoduo
PDD
|
$6.55M |
| 5 |
Cracker Barrel
CBRL
|
$5.94M |
Sector Composition
| 1 | Healthcare | 38.32% |
| 2 | Communication Services | 18.14% |
| 3 | Technology | 10.64% |
| 4 | Consumer Discretionary | 8.64% |
| 5 | Financials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSTH
26
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $2.02M | 0.06% |
102,500
+32,500
| +46% | +$640K |
|
27
American Express
AXP
$225B
| $2.01M | 0.06% |
12,000
+2,000
| +20% | +$335K |
|
28
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.93M | 0.06% |
25,000
+14,500
| +138% | +$1.12M |
|
29
Cantaloupe
CTLP
$795M
| $1.92M | 0.06% |
178,000
+98,000
| +123% | +$1.06M |
|
30
TSMC
TSM
$1.2T
| $1.9M | 0.06% |
17,000
+11,500
| +209% | +$1.28M |
|
31
Apollo Global Management
APO
$75.9B
| $1.88M | 0.06% |
30,500
+27,000
| +771% | +$1.66M |
|
32
Centene
CNC
$14.8B
| $1.87M | 0.06% |
30,000
+27,000
| +900% | +$1.68M |
|
33
Aon
AON
$80.6B
| $1.8M | 0.05% |
+6,300
| New | +$1.8M |
|
34
Pinnacle West Capital
PNW
$10.6B
| $1.8M | 0.05% |
+24,800
| New | +$1.8M |
|
35
Apple
AAPL
$3.54T
| $1.77M | 0.05% |
12,500
-7,500
| -38% | -$1.06M |
|
36
Intellia Therapeutics
NTLA
$1.26B
| $1.74M | 0.05% |
13,000
-12,000
| -48% | -$1.61M |
|
37
Shopify
SHOP
$182B
| $1.63M | 0.05% |
+12,000
| New | +$1.63M |
|
38
Northrop Grumman
NOC
$83.2B
| $1.62M | 0.05% |
4,500
+3,800
| +543% | +$1.37M |
|
|
SAGE
39
DELISTED
Sage Therapeutics
SAGE
| $1.62M | 0.05% |
+36,500
| New | +$1.62M |
|
40
AES
AES
$9.42B
| $1.6M | 0.05% |
70,000
-30,000
| -30% | -$685K |
|
41
Teva Pharmaceuticals
TEVA
$21.5B
| $1.56M | 0.05% |
160,000
| – | – |
|
42
Incyte
INCY
$17B
| $1.51M | 0.05% |
+22,000
| New | +$1.51M |
|
43
Aurinia Pharmaceuticals
AUPH
$1.58B
| $1.51M | 0.05% |
68,000
+58,000
| +580% | +$1.28M |
|
44
Workday
WDAY
$62.3B
| $1.5M | 0.05% |
+6,000
| New | +$1.5M |
|
45
Prudential Financial
PRU
$37.8B
| $1.47M | 0.04% |
14,000
-4,500
| -24% | -$473K |
|
46
Phillips 66
PSX
$52.8B
| $1.47M | 0.04% |
+21,000
| New | +$1.47M |
|
47
Live Nation Entertainment
LYV
$37.6B
| $1.46M | 0.04% |
+16,000
| New | +$1.46M |
|
|
ONC
48
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $1.45M | 0.04% |
+4,000
| New | +$1.45M |
|
49
Amazon
AMZN
$2.41T
| $1.31M | 0.04% |
+8,000
| New | +$1.31M |
|
50
Zoom
ZM
$25B
| $1.31M | 0.04% |
+5,000
| New | +$1.31M |
|